Dr. Reddy's Laboratories (RDY) EBITDA margin US GAAP (year values) |
|||||||||
2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 24.6% | 44.2% | 44.2% | 29.0% | 29.6% | 28.4% | ||
Changes by years, y/y, % | 0pp | +20pp | 0pp | -15pp | +1pp | +14.0% |
Dr. Reddy's Laboratories. EBITDA margin, %
Dr. Reddy's Laboratories. EBITDA margin, changes, pp
Dr. Reddy's Laboratories (RDY) EBITDA margin US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
EBITDA margin, % | ? | 26.2% | 32.0% | 29.5% | 26.1% | 26.1% | 28.4% | |
Changes by years, y/y, % | -4pp | +1pp | +1pp | -14pp | -14pp | |||
Changes by quarters, q/q, % | -14pp | +6pp | -3pp | -3pp | 0pp |